Platelet-derived bio-products : Classification update, applications, concerns and new perspectives
Copyright © 2019 Elsevier Ltd. All rights reserved..
Platelet derived bio-products in the form of platelet rich plasma, plasma rich in growth factors, or plasma-free platelet releasates, are being studied worldwide with the aim of proving their efficacy in tissue regeneration within many different clinical areas, such as traumatology, maxillofacial surgery, ophthalmology, dermatology and otorhinolaryngology, amongst others. The current lack of consensus in the preparation method and application form, or in the quality assessment of each bio-product, precludes adequate interpretation of the relevance of reported clinical outcomes, and, while many in clinicians are very positive about them, many are sceptic. Relevant aspects of these products are considered to propose a classification nomenclature which would aid a comprehensive comparison of clinical outcomes of bio-products of the same characteristics. Finally, the uses of platelet-derived bio-products in in vitro culture (for cell therapy purposes) as a substitute of animal-origin sera, and other future perspectives of applications of platelet-derived bio-products are discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis - 59(2020), 1 vom: 11. Feb., Seite 102716 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Acebes-Huerta, Andrea [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bio-product |
|---|
| Anmerkungen: |
Date Completed 19.10.2020 Date Revised 19.10.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.transci.2019.102716 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305275186 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305275186 | ||
| 003 | DE-627 | ||
| 005 | 20231225120824.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.transci.2019.102716 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1017.xml |
| 035 | |a (DE-627)NLM305275186 | ||
| 035 | |a (NLM)31928859 | ||
| 035 | |a (PII)S1473-0502(19)30289-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Acebes-Huerta, Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Platelet-derived bio-products |b Classification update, applications, concerns and new perspectives |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.10.2020 | ||
| 500 | |a Date Revised 19.10.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Platelet derived bio-products in the form of platelet rich plasma, plasma rich in growth factors, or plasma-free platelet releasates, are being studied worldwide with the aim of proving their efficacy in tissue regeneration within many different clinical areas, such as traumatology, maxillofacial surgery, ophthalmology, dermatology and otorhinolaryngology, amongst others. The current lack of consensus in the preparation method and application form, or in the quality assessment of each bio-product, precludes adequate interpretation of the relevance of reported clinical outcomes, and, while many in clinicians are very positive about them, many are sceptic. Relevant aspects of these products are considered to propose a classification nomenclature which would aid a comprehensive comparison of clinical outcomes of bio-products of the same characteristics. Finally, the uses of platelet-derived bio-products in in vitro culture (for cell therapy purposes) as a substitute of animal-origin sera, and other future perspectives of applications of platelet-derived bio-products are discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Bio-product | |
| 650 | 4 | |a Clinical applications | |
| 650 | 4 | |a Platelet Rich Plasma (PRP) | |
| 650 | 4 | |a Platelets | |
| 650 | 4 | |a Regenerative medicine | |
| 700 | 1 | |a Arias-Fernández, Tamara |e verfasserin |4 aut | |
| 700 | 1 | |a Bernardo, Ángel |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz-Turrillas, María Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Fuertes, Judit |e verfasserin |4 aut | |
| 700 | 1 | |a Seghatchian, Jerard |e verfasserin |4 aut | |
| 700 | 1 | |a Gutiérrez, Laura |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis |d 2001 |g 59(2020), 1 vom: 11. Feb., Seite 102716 |w (DE-627)NLM114008043 |x 1473-0502 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2020 |g number:1 |g day:11 |g month:02 |g pages:102716 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.transci.2019.102716 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2020 |e 1 |b 11 |c 02 |h 102716 | ||